Epratuzumab

Related by string. epratuzumab * * candidate epratuzumab . evaluating epratuzumab *

Related by context. Frequent words. (Click for all words.) 75 Ofatumumab 74 Dasatinib 73 Voreloxin 72 Drug Candidate 72 Bortezomib 72 Lenalidomide 72 Metastatic Colorectal Cancer 72 Monoclonal Antibody 72 Traficet EN 72 Chronic Hepatitis C 71 Bevacizumab 71 mTOR inhibitor 71 Carfilzomib 71 Chronic Lymphocytic Leukemia 70 Alemtuzumab 70 Metastatic Melanoma 70 Pirfenidone 70 Clinical Trial Results 70 Pulmonary Arterial Hypertension 70 Amrubicin 70 Zolinza 70 Bavituximab 70 Monotherapy 70 Rituximab 70 Phase III Trial 70 Preclinical Data 70 elotuzumab 70 humanized anti 70 Irinotecan 69 Mipomersen 69 liposomal formulation 69 Erlotinib 69 Vandetanib 69 Pivotal Phase 69 Trastuzumab 69 Pivotal Phase III 69 CYC# 69 Cethromycin 69 Phase III Clinical Trial 69 humanized monoclonal antibody 68 Onalta 68 Aurora kinase 68 Sym# 68 PXD# 68 KRN# 68 romidepsin 68 Patient Enrollment 68 Perifosine 68 Pivotal Trial 68 tocilizumab 68 indolent NHL 68 R sorafenib tablets 68 Panzem R 68 tyrosine kinase inhibitor 68 pertuzumab 68 EGFr 68 mycophenolate mofetil 67 orally bioavailable 67 Targeted Therapy 67 Completes Enrollment 67 Gemzar ® 67 angiogenesis inhibitor 67 HGS ETR1 67 bevacizumab Avastin 67 cancer immunotherapies 67 BAY #-# 67 Combination Therapy 67 humanized antibody 67 Everolimus 67 phase IIb clinical 67 tumor lysis syndrome 67 TORISEL 67 DAVANAT 67 metastatic renal cell carcinoma 67 ATL# [001] 67 FDA Accepts 67 relapsed multiple myeloma 66 Elesclomol 66 Advanced Prostate Cancer 66 eltrombopag 66 Nexavar ® 66 KNS # 66 OXi# 66 FLT3 66 Azedra 66 CCX# 66 luteinizing hormone releasing 66 cutaneous T cell 66 Solid Tumors 66 HuMax CD# 66 DOXIL 66 Avastin bevacizumab 66 TREANDA 66 Pegasys ® 66 pseudobulbar affect PBA 66 MEK inhibitor 66 hypoxia inducible factor 66 Herceptin trastuzumab 66 Natalizumab 66 Imprime PGG 66 Overactive Bladder

Back to home page